Skip to main content

Table 1 Pathogens distribution of neonatal ventilator-associated pneumonia (VAP) in the NICU of CGMH, October 2017 to September 2020

From: Clinical characteristics and outcomes of neonates with polymicrobial ventilator-associated pneumonia in the intensive care unit

 

Polymicrobial VAP (total n = 60 episodes)

Monomicrobial VAP

(total n = 176 episodes)

MDR pathogens

(total n = 98 bacteria)

Gram-positive cocci

41 (32.5)

44 (25.0)

35 (35.7)

 Methicillin resistant Staphylococcus aureus

20 (15.9)

15 (8.5)

35 (35.7)

 Methicillin sensitive Staphylococcus aureus

18 (14.3)

28 (15.9)

0 (0)

 Enterococcus spp.

1 (0.8)

1 (0.6)

0 (0)

 Group B Streptococcus

2 (1.6)

0 (0)

0 (0)

Gram-negative bacilli

85 (67.5)

122 (69.3)

59 (60.2)

 Klebsiella pneumonia

21 (16.7)

21 (11.9)

13 (13.3)

 Pseudomonas aeruginosa

11 (8.7)

21 (11.9)

6 (6.1)

 Acinetobacter baumannii

15 (11.9)

17 (9.7)

4 (4.1)

 Escherichia coli

9 (10.9)

15 (8.5)

11 (11.2)

 Serratia marcescens

7 (7.1)

14 (8.0)

0 (0)

 Enterobacter spp.

2 (1.6)

19 (10.8)

2 (2.0)

 Stenotrophomonas maltophilia

12 (9.5)

6 (3.4)

18 (18.4)

 Klebsiella aerogenes

5 (4.0)

6 (3.4)

3 (3.1)

 Klebsiella oxytoca

3 (2.4)

3 (1.7)

2 (2.0)

Othersa

0 (0)

10 (5.7)

4 (4.1)

  1. MDR pathogens multidrug-resistant pathogens
  2. aIncluding Burkholderia cepacia (3), Corynebacterium striatum (2), Morganella species (1), Citrobacter koseri (2), Moraxella catarrhalis (1) and Hemophilus influenzae (1)